Conceitos essenciais
Black patients are significantly less likely to receive genetic evaluation and testing for neurologic disorders compared to White patients, indicating disparities in healthcare accessibility.
Resumo
The study highlights racial disparities in genetic testing for neurologic disorders, revealing that Black patients are underrepresented in the evaluation process. Key points include:
- Black patients receive less genetic evaluation than White patients.
- Potential bias in patient referrals for testing.
- Disparities in accessibility to genetic testing.
- Wealth quartiles impact the likelihood of evaluation.
- No disparities in completing genetic testing or receiving diagnostic results.
- Need for addressing healthcare disparities and providing culturally sensitive services.
- Decision support tools to reduce racial disparities in genetic testing.
- Importance of understanding barriers to genetic testing for health equity.
Estatísticas
Black patients were less than half as likely to be evaluated compared with White patients (odds ratio [OR], 0.49; P < .001).
Patients from the least wealthy quartile were less likely to be evaluated (OR, 0.67; P < .001).
73% of patients evaluated for genetic testing were White, while only 11% were Black.
Citações
"This testing is something that everyone, regardless of race or ethnic background, can benefit from." - Colin A. Ellis, MD